Science Explorer Back to mapMap
Discussion
Researcher · Goshen Health · United States

Daniel Bruetman

Daniel Bruetman publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.

OpenAlex
World rank
#3,560,848
of 7,710,434 ranked researchers
Rank in United States
#993,056
of 1,627,098
Works
22
Citations
764
Citations per work
34.7
h-index
8
i10-index 7Top 72% in Oncology
Daniel Bruetman

What does Daniel Bruetman research?

Daniel Bruetman's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (17%).

Health Sciences: 13 works · 60.1% of their workMedicine: 13 works · 60.1% of their workOncology: 7 works · 30.8% of their workPulmonary and Respiratory Medicine: 6 works · 26.2% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 3.1% of their workEverything else: 5 works · 23.0% of their workLife Sciences: 4 works · 16.9% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 16.9% of their workCancer Research: 2 works · 9.2% of their workBiotechnology: 1 works · 4.6% of their workMolecular Biology: 1 works · 3.1% of their workTHEIR WORKDaniel Bruetman22works
Life Sciences17%Health Sciences60%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1360.1%
  2. Everything else523.0%
    1. Biochemistry, Genetics and Molecular Biology416.9%
  1. 1Oncology31% of their works
  2. 2Pulmonary and Respiratory Medicine26% of their works
  3. 3Cancer Research9% of their works
  4. 4Biotechnology5% of their works
  5. 5Molecular Biology3% of their works
  6. 6Radiology, Nuclear Medicine and Imaging3% of their works

Research topics

Which keywords describe Daniel Bruetman's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, Immunotherapy, ALK Inhibitors, EGFR Mutations, Genomic Profiles and Small-Cell Lung Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Clinical Trials212 topics
  2. Targeted Therapy212 topics
  3. Chemotherapy173 topics
  4. Immunotherapy132 topics
  5. ALK Inhibitors111 topic
  6. EGFR Mutations111 topic
  7. Genomic Profiles101 topic
  8. Small-Cell Lung Cancer101 topic
  9. Radiotherapy72 topics
  10. CT Screening51 topic
  11. Lung Cancer51 topic
  12. Bacterial Therapy31 topic
  13. Chemotherapy-Induced Peripheral Neuropathy31 topic
  14. Taxanes31 topic
  15. Tumor Targeting31 topic
  16. Breast Tumours21 topic
  17. DNA21 topic
  18. Gene Expression21 topic
  19. HIF-121 topic
  20. Topoisomerases21 topic
  21. Warburg Effect21 topic

Where does Daniel Bruetman work?

Daniel Bruetman's main affiliation in the publication record is Goshen Health, United States.

How many publications and citations does Daniel Bruetman have?

OpenAlex counts 22 works and 764 citations for Daniel Bruetman, an h-index of 8, ranking #3,560,848 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Daniel Bruetman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.